Search Results - "Stonelake, Paul S"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    The hypercoagulable state of malignancy: pathogenesis and current debate by Caine, Graham J, Stonelake, Paul S, Lip, Gregory Y H, Kehoe, Sean T

    Published in Neoplasia (New York, N.Y.) (01-11-2002)
    “…A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor cells to activate the coagulation system. It has been estimated that…”
    Get full text
    Journal Article
  2. 2

    Circulating Endothelial Cells and Circulating Progenitor Cells in Breast Cancer: Relationship to Endothelial Damage/Dysfunction/ Apoptosis, Clinicopathologic Factors, and the Nottingham Prognostic Index by Goon, Patrick K.Y., Lip, Gregory Y.H., Stonelake, Paul S., Blann, Andrew D.

    Published in Neoplasia (New York, N.Y.) (01-08-2009)
    “…BACKGROUND AND METHODS: Abnormal circulating endothelial cell (CEC) and circulating progenitor cell (CPC) numbers are present in cancer, but their relationship…”
    Get full text
    Journal Article
  3. 3

    Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison by Goon, Patrick K Y, Boos, Christopher J, Stonelake, Paul S, Blann, Andrew D, Lip, Gregory Y H

    Published in Thrombosis and haemostasis (01-07-2006)
    “…Mature circulating endothelial cells (CECs) are novel cellular markers of endothelial damage/dysfunction. The two main techniques of CEC enumeration are flow…”
    Get more information
    Journal Article
  4. 4

    Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma by Caine, Graham J, Lip, Gregory Y H, Stonelake, Paul S, Ryan, Peter, Blann, Andrew D

    Published in Thrombosis and haemostasis (01-07-2004)
    “…In health, haemostasis and angiogenesis are tightly regulated processes, but may become deregulated in cancer. Recent evidence suggests that platelet…”
    Get more information
    Journal Article
  5. 5

    Coagulopathic complications in breast cancer by Caine, Graham J., Stonelake, Paul S., Rea, Daniel, Lip, Gregory Y. H.

    Published in Cancer (15-10-2003)
    “…Patients with cancer are highly susceptible to thromboembolic complications, which account for a significant percentage of the morbidity and mortality of the…”
    Get full text
    Journal Article
  6. 6

    Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer by Ramcharan, Sean K., Lip, Gregory Y. H., Stonelake, Paul S., Blann, Andrew D.

    Published in European journal of clinical investigation (01-08-2013)
    “…Background Circulating endothelial cells (CECs), endothelial progenitor cells (EPCs), Willebrand factor (vWf), soluble E‐selectin, vascular endothelial growth…”
    Get full text
    Journal Article
  7. 7

    Use of Multiple Drains After Mastectomy Is Associated With More Patient Discomfort and Longer Postoperative Stay by Saratzis, Athanasios, Soumian, Soni, Willetts, Rachel, Sarah Rastall, Sarah, Stonelake, Paul S

    Published in Clinical breast cancer (01-11-2009)
    “…Abstract Background Seromas constitute a common complication following surgery for breast cancer, and closed drainage is used routinely to reduce its…”
    Get full text
    Journal Article
  8. 8

    The endotheliome: A new concept in vascular biology by Ramcharan, Khedar S, Lip, Gregory Y.H, Stonelake, Paul S, Blann, Andrew D

    Published in Thrombosis research (01-07-2011)
    “…Abstract As the importance of the endothelium is becoming increasingly recognised, additional tools are needed to assess its functions. Separate studies have…”
    Get full text
    Journal Article
  9. 9

    Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer by Caine, Graham J, Stonelake, Paul S, Lip, Gregory Y.H, Blann, Andrew D

    Published in Cancer letters (08-04-2007)
    “…Abstract Background Vascular endothelial growth factor (VEGF), a major angiogenic growth factor, is involved in the pathogenesis of cancer. Plasma VEGF is…”
    Get full text
    Journal Article
  10. 10

    Hypertension, anti-hypertensive therapy and neoplasia by Goon, Patrick K Y, Stonelake, Paul S, Lip, Gregory Y H

    Published in Current pharmaceutical design (01-09-2007)
    “…The link between cancer, hypertension and anti-hypertensive drug treatment is controversial. Despite numerous studies looking either directly or indirectly at…”
    Get more information
    Journal Article
  11. 11

    A comparison of plasma versus histologic indices of angiogenic markers in breast cancer by Caine, Graham J, Lip, Gregory, Zanetto, Ulyses, Maheshwari, Mahwandra, Stonelake, Paul S, Blann, Andrew D

    “…Over-expression of angiogenic growth factors and their receptors, and high levels of these molecules in the blood, are a common feature of cancer although the…”
    Get full text
    Journal Article
  12. 12

    Circulating endothelial cells in malignant disease by Goon, Patrick K Y, Boos, Christopher J, Stonelake, Paul S, Lip, Gregory Y H

    Published in Future oncology (London, England) (01-12-2005)
    “…Cancer is a disease largely dependent on neoangiogenesis. Cancer neoangiogenesis is often disordered and abnormal, with evidence of coexisting vascular…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Platelet adhesion in breast cancer: development and application of a novel assay by Caine, Graham J, Nadar, Sunil K, Lip, Gregory YH, Stonelake, Paul S, Blann, Andrew D

    Published in Blood coagulation & fibrinolysis (01-09-2004)
    “…The increased risk of thromboembolism in cancer may be related to a prothrombotic or hypercoagulable state, with abnormalities of haemostasis and platelet…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Angiogenin outperforms VEGF , EPC s and CEC s in predicting D ukes' and AJCC stage in colorectal cancer by Ramcharan, Sean K., Lip, Gregory Y. H., Stonelake, Paul S., Blann, Andrew D.

    Published in European journal of clinical investigation (01-08-2013)
    “…Abstract Background Circulating endothelial cells ( CEC s), endothelial progenitor cells ( EPC s), W illebrand factor (v W f), soluble E ‐selectin, vascular…”
    Get full text
    Journal Article
  18. 18

    A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer by Hoar, F.J., Stonelake, P.S.

    Published in European journal of surgical oncology (01-08-2003)
    “…Aims: Limitations of sentinel lymph node biopsy (SLNB) include the occurrence of false negative (FN) results and the need to further treat SLNB positive…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate1 by Caine, Graham J, Stonelake, Paul S, Lip, Gregory YH, Kehoe, Sean T

    Published in Neoplasia (New York, N.Y.) (01-11-2002)
    “…A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor cells to activate the coagulation system. It has been estimated that…”
    Get full text
    Journal Article